Frontlight ResearchEarly access
ANCA-associated vasculitis trials in Netherlands
6 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in NetherlandsRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Rotterdam
- Age
- 6 years and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - Phase 3Taking peopleA Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
- Where
- Rotterdam
- Age
- 6 years to 17 years
- People
- 14 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06512883 · EU 2023-508533-14-00 - Phase 3Not yet taking people in NetherlandsROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
- Where
- Rotterdam
- People
- 94 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-523307-29-00 - Phase 4Not yet taking people in NetherlandsDiscontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)
- Where
- DO NOT EDIT
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Region Oestergoetland
See details and how to join2023-508398-10-00 - Phase 4Taking peopleEvaluating, clinical and immunological effects of rituximab with cyclophosphamide compared to rituximab alone in AAV patients
- Where
- Alkmaar, Amersfoort, Amsterdam, Breda, Leiden, Rotterdam, 's-Gravenhage
- Age
- 18 years and over
- People
- 100
- Run by
- Academisch Ziekenhuis Leiden
See details and how to join2023-507868-39-00 - Phase 4Taking peopleeGPA and local inflammation within the ENT area
- Where
- Groningen
- Age
- 18 years and over
- People
- 150
- Run by
- Universitair Medisch Centrum Groningen
See details and how to join2023-508029-28-00